Shares of Fresenius Medical Care have moved 11.7% today, and are now trading at a price of $20.85. In contrast, the S&P 500 index saw a -1.0% change. Today's trading volume is 396,238 compared to the stock's average volume of 404,761.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. Based in Bad Homburg, Germany the company has 119,845 full time employees and a market cap of $12,613,664,768. Fresenius Medical Care currently offers its equity investors a dividend that yields 6.4% per year.
The company is now trading 7.7% away from its average analyst target price of $19.36 per share. The 4 analysts following the stock have set target prices ranging from $15.01 to $24.01, and on average give Fresenius Medical Care a rating of underperform.
Over the last 12 months FMS shares have declined by -1.9%, which represents a difference of -30.6% when compared to the S&P 500. The stock's 52 week high is $27.72 per share and its 52 week low is $16.37. With its net margins declining an average -27.7% over the last 5 years, Fresenius Medical Care declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 4,936,237 | 84,351 | 2 | -33.33 |
| 2022 | 19,398,017 | 673,405 | 3 | -50.0 |
| 2021 | 17,618,685 | 969,308 | 6 | -14.29 |
| 2020 | 17,859,063 | 1,164,377 | 7 | 0.0 |
| 2019 | 17,476,555 | 1,199,619 | 7 | -41.67 |
| 2018 | 16,546,873 | 1,981,924 | 12 | n/a |
